|
|
|
Financial liabilities |
|
|
|
|
at amortized cost |
|
|
Financial liabilities |
|
US $ |
|
|
2017 |
|
|
|
|
Trade and other payables |
|
10,889,554 |
|
|
Payable on completion of clinical trial |
|
500,000 |
|
|
Derivative liabilities |
|
12,626,299 |
|
|
|
|
|
|
|
|
|
24,015,853 |
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
|
|
Trade and other payables |
|
12,319,117 |
|
|
Payable on completion of clinical trial |
|
500,000 |
|
|
Derivative liabilities |
|
5,798,058 |
|
|
|
|
|
|
|
|
|
18,617,175 |
|
|
|
|
|
|